Factors Affecting the Price of BRAFTOVI

BRAFTOVI (encorafenib), a kinase inhibitor for specific cancers, has a price influenced by multiple factors. 

Factors Affecting the Price of BRAFTOVI

Firstly, R&D costs are high. Developing this drug for BRAF V600 - mutated cancers involved substantial investment in research and clinical trials.

Moreover, production costs matter. Precise manufacturing processes and strict quality control add to expenses. Market demand also impacts the price. If the demand for treating melanoma or colorectal cancer with this drug is high, prices may be maintained at a certain level.